好评率
100%
  • Mao S; Zhang W; Yang F, et al., Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA. J Exp Clin Cancer Res 2021, 40 (1), 336.
    IF: 11.161
    Year: 2021 Journal: J Exp Clin Cancer Res
    PubMed: 34696782
  • Zhang Y; Yin C; Wei C, et al., Exosomal miR-625-3p secreted by cancer-associated fibroblasts in colorectal cancer promotes EMT and chemotherapeutic resistance by blocking the CELF2/WWOX pathway. Pharmacol Res 2022, 186, 106534.
    IF: 10.334
    Year: 2022 Journal: Pharmacol Res
    PubMed: 36336217
  • Lai F; Wang H; Zhao X, et al., RNF20 is required for male fertility through regulation of H2B ubiquitination in the Sertoli cells. Cell Biosci 2023, 13 (1), 71.
    IF: 9.584
    Year: 2023 Journal: Cell Biosci
    PubMed: 37024990
  • Ren Y; Cao L; Wang L, et al., Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFkappaB signaling. Cell Death Dis 2021, 12 (10), 858.
    IF: 8.469
    Year: 2021 Journal: Cell Death Dis
    PubMed: 34552063
  • Zhang Q C; Qian Y M; Ren Y H, et al., Phenethyl isothiocyanate inhibits metastasis potential of non-small cell lung cancer cells through FTO mediated TLE1 m(6)A modification. Acta Pharmacol Sin 2023.
    IF: 8.2
    Year: 2023 Journal: Acta Pharmacol Sin
    PubMed: 37848553
  • Wu Q; Tong L; Zou Z, et al., Herceptin-functionalized SK-BR-3 cell membrane-wrapped paclitaxel nanocrystals for enhancing the targeted therapy effect of HER2-positive breast cancer. Materials & Design 2022, 110818.
    IF: 7.991
    Year: 2022 Journal: Mater Design
    DOI:10.1016/j.matdes.2022.110818
  • Du J; Liu X; Sun J, et al., Trastuzumab-functionalized bionic pyrotinib liposomes for targeted therapy of HER2-positive breast cancer. Breast Cancer Res 2024, 26 (1), 99.
    IF: 7.4
    Year: 2024 Journal: Breast Cancer Res
    PubMed: 38867302
  • Zhang M; Chen Y; Liu Z, et al., Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial-Mesenchymal Transition and Arousing Immune Response. J Med Chem 2024.
    IF: 7.3
    Year: 2024 Journal: J Med Chem
    PubMed: 38232132
  • Yang L; Zheng L; Xie X, et al., Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer. J Adv Res 2022, 36, 265-276.
    IF: 6.992
    Year: 2021 Journal: J Adv Res
    PubMed: 35127176
  • Chen Y; Zhang M; He Y, et al., Canadine Platinum(IV) Complexes Targeting Epithelial-Mesenchymal Transition as Antiproliferative and Antimetastatic Agents. J Med Chem 2024, 67 (15), 12868-12886.
    IF: 6.8
    Year: 2024 Journal: J Med Chem
    PubMed: 39069665
  • Qian R; Niu X; Wang Y, et al., Targeting MALT1 Suppresses the Malignant Progression of Colorectal Cancer via miR-375/miR-365a-3p/NF-kappaB Axis. Front Cell Dev Biol 2022, 10, 845048.
    IF: 6.684
    Year: 2022 Journal: Front Cell Dev Biol
    PubMed: 35309901
  • Shen W; Ge S; Liu X, et al., Folate-functionalized SMMC-7721 liver cancer cell membrane-cloaked paclitaxel nanocrystals for targeted chemotherapy of hepatoma. Drug Deliv 2022, 29 (1), 31-42.
    IF: 6.419
    Year: 2021 Journal: Drug Deliv
    PubMed: 34962215
  • Lu Y, Huang R, Sun Z, et al. A bovine milk-derived peptide ameliorates pancreatic β-cell dedifferentiation through PI3K/Akt/FOXO1 signaling in type 2 diabetes[J]. Food & Function, 2023.
    IF: 6.1
    Year: 2023 Journal: Food Funct
    PubMed: 37593938
  • Huang Y; Xian L; Liu Z, et al., AMPKalpha2/HNF4A/BORIS/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment. Biochem Pharmacol 2022, 115198.
    IF: 6.1
    Year: 2022 Journal: Biochem Pharmacol
    PubMed: 35940258
  • Yang L; Hu L; Tang H, et al., The disruption of human trophoblast functions by autophagy activation through PI3K/AKT/mTOR pathway induced by exposure to titanium carbide (Ti3C2) MXene. Food Chem Toxicol 2022, 113128.
    IF: 6.023
    Year: 2022 Journal: Food Chem Toxicol
    PubMed: 35569596
  • Chen L J; Wu L; Wang W, et al., Long noncoding RNA 01614 hyperactivates WNT/betacatenin signaling to promote pancreatic cancer progression by suppressing GSK3beta. Int J Oncol 2022, 61 (4).
    IF: 5.884
    Year: 2022 Journal: Int J Oncol
    PubMed: 35929518
  • Fan C-W; Tang J; Jiang J-C, et al., Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo. Phytomedicine 2022, 154192.
    IF: 5.34
    Year: 2022 Journal: Phytomedicine
    PubMed: 35636179
  • Liu H; Liu Y; Sun P, et al., Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression. Clin Sci (Lond) 2020, 134 (4), 419-434.
    IF: 5.237
    Year: 2020 Journal: Clin Sci
    PubMed: 32065214
  • He J; Wu F; Li J, et al., Tumor suppressor CLCA1 inhibits angiogenesis via TGFB1/SMAD/VEGF cascade and sensitizes hepatocellular carcinoma cells to Sorafenib. Dig Liver Dis 2023.
    IF: 5.165
    Year: 2023 Journal: Dig Liver Dis
    PubMed: 37230858
  • Chen Y H; Yang S H; Liu L X, et al., Knockdown of FGFR3 inhibits the proliferation, migration and invasion of intrahepatic cholangiocarcinoma. Dig Liver Dis 2022.
    IF: 5.165
    Year: 2022 Journal: Dig Liver Dis
    PubMed: 35999136
  • Zhao S; Xue H; Hao C L, et al., BTG1 Overexpression Might Promote Invasion and Metastasis of Colorectal Cancer via Decreasing Adhesion and Inducing Epithelial-Mesenchymal Transition. Front Oncol 2020, 10, 598192.
    IF: 4.848
    Year: 2020 Journal: Front Oncol
    PubMed: 33330092
  • Huang W; Liu M; Xiao B, et al., Aflatoxin B1 disrupts blood-testis barrier integrity by reducing junction protein and promoting apoptosis in mice testes. Food Chem Toxicol 2021, 148, 111972.
    IF: 4.679
    Year: 2021 Journal: Food Chem Toxicol
    PubMed: 33421461
  • Wang Y; Yang J; Chang X, et al., Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF-kappaB/NLRP3 Inflammasome Pathway. Mol Nutr Food Res 2024, 68 (16), e2400215.
    IF: 4.5
    Year: 2024 Journal: Mol Nutr Food Res
    PubMed: 39082076
  • Shen W; Li Y; Li B, et al., Downregulation of KCTD12 contributes to melanoma stemness by modulating CD271. Cancer Biol Med 2019, 16 (3), 498-513.
    IF: 4.467
    Year: 2019 Journal: Cancer Biol Med
    PubMed: 31565480
  • Li Q; Peng W; Zhang Z, et al., A phycocyanin derived eicosapeptide attenuates lung fibrosis development. Eur J Pharmacol 2021, 908, 174356.
    IF: 4.432
    Year: 2021 Journal: Eur J Pharmacol
    PubMed: 34280398
  • Qi Y; Dong S S; He Y L, et al., SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-beta1/Smad signaling. BMC Cancer 2022, 22 (1), 166.
    IF: 4.43
    Year: 2022 Journal: BMC Cancer
    PubMed: 35151264
  • Xue T; Wang X; Pan X, et al., PTX promotes breast cancer migration and invasion by recruiting ATF4 to upregulate FGF19. Cell Signal 2024, 122, 111309.
    IF: 4.4
    Year: 2024 Journal: Cell Signal
    PubMed: 39053672
  • Liu F; Li X; Yan H, et al., Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer. Cell Signal 2022, 92, 110267.
    IF: 4.315
    Year: 2022 Journal: Cell Signal
    PubMed: 35108639
  • Liu E; Qian X; He Y, et al., FUT4 promotes the progression of Cholangiocarcinoma by modulating epithelial-mesenchymal transition. Cell Cycle 2024, 1-14.
    IF: 4.3
    Year: 2024 Journal: Cell Cycle
    PubMed: 38466946
  • Du Y; Chen Y; Yan Z, et al., Zinc finger protein 263 promotes colorectal cancer cell progression by activating STAT3 and enhancing chemoradiotherapy resistance. Sci Rep 2024, 14 (1), 21827.
    IF: 3.8
    Year: 2024 Journal: Sci Rep-UK
    PubMed: 39294234
  • Deng X; Zhen P; Niu X, et al., APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma. J Dermatol Sci 2020, 100 (1), 67-74.
    IF: 3.681
    Year: 2020 Journal: J Dermatol Sci
    PubMed: 32951990
  • Zhang B; Zhang C; Yang X, et al., Cytoplasmic collagen XIalphaI as a prognostic biomarker in esophageal squamous cell carcinoma. Cancer Biol Ther 2018, 19 (5), 364-372.
    IF: 3.294
    Year: 2018 Journal: Cancer Biol Ther
    PubMed: 29333916
  • Li J; Li Z; Wang C, et al., The regulatory effect of VEGF-Ax on rat bone marrow mesenchymal stem cells angioblastic differentiation and its pro-angiogenic ability. Stem Cells Dev 2020.
    IF: 3.147
    Year: 2020 Journal: Stem Cells Dev
    PubMed: 32079499
  • Liu J; Li W; Lu R, et al., Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinoma. Oncol Res 2024, 32 (4), 717-726.
    IF: 3.1
    Year: 2024 Journal: Oncol Res
    PubMed: 38560576
0
产品咨询微信

服务热线

400-602-0407

APP下载
生物狗小程序